International Flavors & Fragrances (IFF) just announced two science-backed product milestones: a canine probiotic called PureStrong and a heart health claim for its isolated soy protein in Australia and New Zealand, broadening its reach across pet care and nutrition.

The latest product news lands as the share price sits at $72.52, with a 30-day share price return of 5.53% and a 1-year total shareholder return of 1.52%. The 5-year total shareholder return of a 41.95% decline points to longer term underperformance and still-rebuilding momentum.

If this kind of science-led story has your attention, it could be a good moment to broaden your watchlist and check out 18 top founder-led companies

With IFF trading at $72.52 and indicators such as an intrinsic discount and a gap to analyst targets, the key question is whether recent science-led wins leave upside on the table or whether the market already reflects future growth.

Most Popular Narrative: 20% Undervalued

Against a fair value estimate of $90.71, the current $72.52 price sits at a discount, and the most followed narrative ties that gap to long term portfolio reshaping and profit recovery.

Recent divestitures of commodity businesses (e.g., Pharma Solutions, Soy Crush, Concentrates, Lecithin) and the ongoing strategic evaluation of the Food Ingredients segment are increasing IFF's focus on differentiated, higher-margin, innovation-driven products, supporting future margin expansion and higher earnings quality.

Curious what has to happen inside IFF for that valuation to make sense? Revenue barely growing, margins flipping from loss to profit, and a future earnings multiple above sector norms all sit at the heart of this narrative, with detailed assumptions on timing and scale left for you to unpack.

Result: Fair Value of $90.71 (UNDERVALUED)

However, softness in key markets and pressure in fragrance ingredients could still weigh on margins and weaken the optimistic earnings path underlying that 20% undervalued story.

Next Steps

With both risks and rewards on the table, do you feel the story is leaning bullish or cautious? Consider acting promptly by reviewing the data and weighing up the 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If IFF has sharpened your interest, do not stop here, use the Simply Wall St Screener to quickly surface fresh stock ideas that match your style.

• Target resilient compounding potential by reviewing companies with reliable payouts and strong profiles through the 11 dividend fortresses.
• Hunt for opportunities where quality and price still look aligned by scanning the 58 high quality undervalued stocks.
• Prioritize capital preservation and steadier return profiles by filtering for companies in the 72 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.